Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

被引:20
作者
Domenech, Eugeni [1 ,2 ]
Garcia, Valle [3 ]
Iborra, Marisa [4 ]
Gutierrez, Ana [5 ,6 ]
Garcia-Lopez, Santiago [7 ]
Martin Arranz, Maria D. [8 ]
Garcia-Planella, Esther [9 ]
Calvo, Marta [10 ]
Castro, Luisa [11 ]
Minguez, Miguel [12 ]
Taxonera, Carlos [13 ]
Julia, Berta [14 ]
Cea-Calvo, Luis [14 ]
Romero, Cristina [14 ]
Barreiro-de Acosta, Andmanuel [15 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Serv Aparato Digest, Badalona, Spain
[2] CIBERehd, Badalona, Spain
[3] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Unidad Gest Clin Aparato Digest, Cordoba, Spain
[4] Hosp La Fe, Serv Gastroenterol, Valencia, Spain
[5] Univ Alicante, Hosp Gen, Serv Med Digest, Madrid, Spain
[6] Inst Salud Carlos III, CIBEREHD, Madrid, Spain
[7] Hosp Univ Miguel Servet, Serv Gastroenterol, Zaragoza, Spain
[8] Hosp Univ La Paz, Serv Aparato Digest, IdiPaz, Madrid, Spain
[9] Hosp Santa Creu & Sant Pau, Serv Patol Digest, Barcelona, Spain
[10] Hosp Puerta de Hierro, Serv Gastroenterol, Madrid, Spain
[11] Hosp Virgen Macarena, Unidad Gastroenterol, Seville, Spain
[12] Univ Valencia, Hosp Clin Valencia, Serv Med Digest, Valencia, Spain
[13] Hosp Clin San Carlos, Serv Gastroenterol, Madrid, Spain
[14] MSD, Dept Med, Madrid 28027, Spain
[15] Complejo Hosp Univ Santiago, Serv Aparato Digest, Unidad Enfermedad Inflamatoria Intestinal, Santiago De Compostela, Spain
关键词
Crohn's disease; postoperative recurrence; intestinal resection; prophylaxis; PLACEBO-CONTROLLED TRIAL; POSTOPERATIVE RECURRENCE; NATURAL-HISTORY; RISK-FACTORS; ILEOCOLONIC RESECTION; RANDOMIZED-TRIAL; DOUBLE-BLIND; METRONIDAZOLE; SURGERY; AZATHIOPRINE;
D O I
10.1097/MIB.0000000000001180
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: More than 50% of patients with Crohn's disease require intestinal resection at least once. Postoperative recurrence (POR) is almost uniform if prophylactic treatment is not started early. Endoscopic monitoring is generally advised. We studied the incidence and management of recurrence in patients who had undergone intestinal resection. Methods: Practicrohn was an observational retrospective study performed in 26 Spanish hospitals including patients aged >= 18 years who underwent Crohn's disease-related ileocolonic resection between January 2007 and December 2010. We recorded preventive treatments, the incidence of clinical recurrence in daily practice, and associated risk factors. Results: The study population comprised 314 patients. Median (interquartile range) time from diagnosis to surgery was 6 (1-12) years. Prophylaxis for POR was administered to 208 patients (68%). Endoscopy was performed in 143 (46%) patients the first year after surgery. Clinical POR was detected in 97 patients (31%) after a median 315 (65-748) days. The cumulative probability of clinical POR was 16%, 27%, and 31% at 1, 3, and 5 years, respectively, being higher among patients not receiving immunomodulators as compared to those who received prophylaxis (P = 0.014). Forty-five patients (14%) required reoperation at 5 years after a median time from the first intervention of 228 (133-527) days. Conclusions: In this real-life study, up to one-third of patients with Crohn's disease did not start preventive therapy after intestinal resection, and almost half of them were not endoscopically monitored as recommended. In this setting, 30% of patients developed clinical POR within the first 5 years after surgery, thus indicating that there is room for improvement.
引用
收藏
页码:1840 / 1846
页数:7
相关论文
共 22 条
  • [1] Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease
    Bernell, O
    Lapidus, A
    Hellers, G
    [J]. BRITISH JOURNAL OF SURGERY, 2000, 87 (12) : 1697 - 1701
  • [2] PROGNOSIS IN CROHNS-DISEASE - BASED ON RESULTS FROM A REGIONAL PATIENT GROUP FROM THE COUNTY OF COPENHAGEN
    BINDER, V
    HENDRIKSEN, C
    KREINER, S
    [J]. GUT, 1985, 26 (02) : 146 - 150
  • [3] Review article: the natural history of postoperative Crohn's disease recurrence
    Buisson, A.
    Chevaux, J. -B.
    Allen, P. B.
    Bommelaer, G.
    Peyrin-Biroulet, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (06) : 625 - 633
  • [4] Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
    D'Haens, Geert R.
    Vermeire, Severine
    Van Assche, Gert
    Noman, Maja
    Aerden, Isolde
    Van Olmew, Gust
    Rutgeerts, Paul
    [J]. GASTROENTEROLOGY, 2008, 135 (04) : 1123 - 1129
  • [5] Crohn's disease management after intestinal resection: a randomised trial
    De Cruz, Peter
    Kamm, Michael A.
    Hamilton, Amy L.
    Ritchie, Kathryn J.
    Krejany, Efrosinia O.
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Gibson, Peter R.
    Sparrow, Miles
    Leong, Rupert W.
    Florin, Timothy H.
    Gearry, Richard B.
    Radford-Smith, Graham
    Macrae, Finlay A.
    Debinski, Henry
    Selby, Warwick
    Kronborg, Ian
    Johnston, Michael J.
    Woods, Rodney
    Elliott, P. Ross
    Bell, Sally J.
    Brown, Steven J.
    Connell, William R.
    Desmond, Paul V.
    [J]. LANCET, 2015, 385 (9976) : 1406 - 1417
  • [6] 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations (Publication with Expression of Concern)
    Gionchetti, Paolo
    Dignass, Axel
    Danese, Silvio
    Magro Dias, Fernando Jose
    Rogler, Gerhard
    Lakatos, Peter Laszlo
    Adamina, Michel
    Ardizzone, Sandro
    Buskens, Christianne J.
    Sebastian, Shaji
    Laureti, Silvio
    Sampietro, Gianluca M.
    Vucelic, Boris
    van der Woude, C. Janneke
    Barreiro-de Acosta, Manuel
    Maaser, Christian
    Portela, Francisco
    Vavricka, Stephan R.
    Gomollon, Fernando
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (02) : 135 - 149
  • [7] Gomollon F., 2016, J Crohns Colitis, pjjw168
  • [8] CROHNS-DISEASE - A LONG-TERM STUDY OF THE CLINICAL COURSE IN 186 PATIENTS
    KRAUSE, U
    EJERBLAD, S
    BERGMAN, L
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1985, 20 (04) : 516 - 524
  • [9] The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review
    Loftus, EV
    Schoenfeld, P
    Sandborn, WJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (01) : 51 - 60
  • [10] Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Manosa, Miriam
    Cabre, Eduard
    Bernal, Isabel
    Esteve, Maria
    Garcia-Planella, Esther
    Ricart, Elena
    Penalva, Mireia
    Cortes, Xavier
    Boix, Jaume
    Pinol, Marta
    Gassull, Miquel A.
    Domenech, Eugeni
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) : 1889 - 1895